Neuphoria Therapeutics Inc Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Neuphoria Therapeutics Inc is a biotechnology research company based at 100 Summit Drive, Burlington, Massachusetts, with 11-50 employees. The company aims to develop therapies for neuropsychiatric disorders, pursuing novel approaches and advancing scientific understanding. Its website at https://neuphoriatx.com lists its pipeline and opportunities for collaboration. In August 2025, Neuphoria Therapeutics announced a collaboration with Merck to expand its pipeline beyond BNC210. In December 2025, the company disclosed development capital financing.